fda warning letters glp-1 september 2025 news Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s FDA issued 25 warning letters

GPR142 prompts glucagon-like Peptide-1 release from islets to improve beta cell function

These are all common and important considerations

Glucagon-like-peptide-1 receptor agonists (GLP-1s), including medications like Ozempic and Zepbound, have transformed weight management and treatment of chronic disease

Researchers have studied GLP-1 receptor agonists because Alzheimers disease overlaps with insulin resistance, inflammation, vascular dysfunction, and metabolic disease

But some people using the drug to manage weight might feel comfortable taking the GLP-1 up until they find out that theyre pregnant

Some of em areclaim to help with potential muscle loss cause that is something that has been noted with the GLP-1 weight-loss drugs